IGC Pharma IGC
NYSE IGC
$0.25 +0.00 (+0.20%)
As of: Oct 21, 2026 · 3:54 PM EDT

IGC Pharma (IGC) EBITDA (2010 - 2026)

Updated

IGC Pharma (IGC) recorded EBITDA of -$2.4 million in FY2026, compared with -$6.83 million in FY2025.

Analysis

IGC Pharma (IGC) EBITDA (2010 - 2026) Analysis & Trends

Starting with FY2011, IGC Pharma's EBITDA history includes 16 years.

  • The FY2026 figure is the highest annual EBITDA since FY2018.
  • Per Business Quant data, IGC's EBITDA was -$6.83 million in FY2025, -$9.16 million in FY2024, -$10.91 million in FY2023 and -$14.78 million in FY2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 12.29 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 9.10 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 8.33 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn 999.00 Mn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn -
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 5.09 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 4.63 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn -9.70 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn 5.89 Bn
10 IGC Pharma 24.10 Mn 21.34 Mn 55,000.00 -2.40 Mn
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 -2.40 Mn
Sep 30, 2025 -2.78 Mn
Jun 30, 2025 -1.76 Mn
Mar 31, 2025 -1.26 Mn
Dec 31, 2024 -1.72 Mn
Sep 30, 2024 -1.62 Mn
Jun 30, 2024 -2.23 Mn
Mar 31, 2024 -2.01 Mn
Dec 31, 2023 -2.84 Mn
Sep 30, 2023 -2.33 Mn
Jun 30, 2023 -1.98 Mn
Mar 31, 2023 -3.89 Mn
Dec 31, 2022 -2.11 Mn
Sep 30, 2022 -2.32 Mn
Jun 30, 2022 -2.64 Mn
Mar 31, 2022 -6.34 Mn
Dec 31, 2021 -2.22 Mn
Sep 30, 2021 -4.19 Mn
Jun 30, 2021 -2.04 Mn
Mar 31, 2021 -2.63 Mn
API Access

IGC Pharma EBITDA API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebitda&ticker=IGC&period=max&api_key=YOUR_API_KEY